10-Q quarterly report · filed Nov 5, 2026

Definitive Healthcare Corp. (DH) Q3 2026 10-Q Quarterly Report

Short answer

Definitive Healthcare Corp. (DH) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $55M (down 9.0% year over year) with net income of −$4M.

Q3 2026 key financials · XBRL

Revenue
$55M
−9.0% YoY · −1.0% QoQ
Net income
−$4M
+73.8% YoY · +28.2% QoQ
Operating margin
-9.1%
Gross margin
77.3%
EPS (diluted)
−$0.03
+80.0% YoY · +40.0% QoQ

Source: XBRL data from the Definitive Healthcare Corp. (DH) Q3 2026 10-Q on SEC EDGAR. USD.

Definitive Healthcare Corp. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $54.7M, down 9% YoY from $60.0M, driven by $5.5M lower subscription revenue
  • Gross margin 77.3% vs 76.6% YoY, with gross profit $42.2M vs $46.0M
  • Existing-customer revenue fell $8.4M, partially offset by $3.0M from new customers
  • Cash $177.1M plus $12.8M short-term investments, with $34.4M operating cash flow through nine months
  • 2026 outlook: negative revenue growth, pressured by churn, elongated deal cycles, and sales execution challenges

Risk Factors

  • Nasdaq delisting risk: bid price fell below $1.00 for 30 consecutive business days, though compliance was regained October 30, 2026
  • Acquisition proposal risk: Advent submitted a non-binding indication of interest on September 2, 2026
  • Strategic transaction risk: proposal uncertainty could divert management time and resources
  • Legal risk: litigation connected to the Advent proposal could generate substantial costs
  • Financing risk: potential Nasdaq delisting could limit access to debt and equity financing

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Definitive Healthcare Corp. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.